1931 — IVD Medical Holding Income Statement
0.000.00%
- HK$2.75bn
- HK$1.69bn
- CNY3.16bn
- 67
- 88
- 22
- 65
Annual income statement for IVD Medical Holding, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,428 | 2,731 | 2,749 | 3,088 | 3,162 |
Cost of Revenue | |||||
Gross Profit | 476 | 566 | 608 | 672 | 751 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,178 | 2,464 | 2,423 | 2,686 | 2,695 |
Operating Profit | 250 | 267 | 326 | 403 | 468 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 232 | 268 | 284 | 339 | 402 |
Provision for Income Taxes | |||||
Net Income After Taxes | 155 | 162 | 196 | 237 | 266 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 159 | 175 | 210 | 238 | 260 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 159 | 175 | 210 | 238 | 260 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.119 | 0.137 | 0.165 | 0.177 | 0.174 |
Dividends per Share |